Where Vision Becomes Reality

Read More

Stason currently holds a portfolio of approved ANDAs

Read More

Developing Products. Building Partnerships

Read More

Quality cannot be tested into products; it has to be built in by Design

Read More


Stason entered the US generic market in 1994, and currently holds a portfolio of approved ANDAs.


Stasons cutting-edge cGMP manufacturing capabilities include facilities from pilot plant and clinical


In 2008, Stason launched the Brand Division when we acquired exclusive development


We partner with North American & European companies to license products into Asia

Development Services

Stason offers contract services to drug development companies that need a qualified facility and support staff with capabilities to formulate, optimize and test, clinical trial materials and commercial products.


Celebrating 20 Years

  • CPhI Worldwide.

"US-based manufacturing, global distribution network.”
  • client3

    Stason Animal Health - "Coming to Kansas!"